Evaluation of adverse events in cats receiving long-term piroxicam therapy for various neoplasms
- 1 April 2010
- journal article
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 12 (4) , 262-268
Abstract
The role of cyclo-oxygenase 2 (COX-2) and prostaglandins (PG) in carcinogenesis has been documented in many species. Piroxicam has shown efficacy against several neoplasms and is frequently prescribed for chronic use. There are no studies investigating chronic piroxicam administration in cats and the chronic use of non-steroidal anti-inflammatory agents in this species has long been cautioned against. This retrospective study aimed to evaluate adverse effects in cats receiving long-term daily piroxicam. Seventy-three cats received daily piroxicam at doses of 0.13–0.41 mg/kg. Treatment duration ranged from 1 to 38 months. Treatment with piroxicam was found to significantly increase frequency of vomiting during the first month of therapy, though this was most significant for cats receiving concurrent chemotherapy. Piroxicam administration was not significantly associated with hematologic, renal or hepatic toxicities. Adverse events were not correlated with dosage. Adverse events were reported in 29% of cats, and were generally mild and transient. Eight percent discontinued piroxicam due to adverse reaction, and 4% due to difficult administration. This study indicates that long-term daily piroxicam is generally well tolerated in cats at conventional doses.Keywords
This publication has 15 references indexed in Scilit:
- Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observationsJournal of Experimental & Clinical Cancer Research, 2008
- Phase I Clinical Evaluation of Carboplatin in Tumor-Bearing Cats: A Veterinary Cooperative Oncology Group StudyJournal of Veterinary Internal Medicine, 2008
- In Vitro Cyclooxygenase-2 Protein Expression and Enzymatic Activity in Neoplastic CellsJournal of Veterinary Internal Medicine, 2007
- Nonsteroidal anti-inflammatory drugs in cats: a reviewVeterinary Anaesthesia and Analgesia, 2007
- Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004)Journal of the American Veterinary Medical Association, 2007
- Cystic Nasal Adenocarcinoma in a Cat Treated With Piroxicam and ChemoembolizationJournal of the American Animal Hospital Association, 2007
- Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the catJournal of Veterinary Pharmacology and Therapeutics, 2005
- Recent Developments in Nonsteroidal Antiinflammatory Drugs in CatsJournal of the American Animal Hospital Association, 2005
- Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)?Biochemical Pharmacology, 2002
- Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary BladderJournal of Veterinary Internal Medicine, 1994